Kohortenstudie
Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”
Congenital Anomalies · 2026-01 · 66 (1)
DOI: 10.1002/cga.70062 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Congenital Anomalies, online erschienen am 12.05.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”. Congenital Anomalies, 66(1). https://doi.org/10.1002/cga.70062
Vancouver
Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”. Congenital Anomalies. 2026;66(1). doi:10.1002/cga.70062
BibTeX
@article{euvimed2026,
title = {Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”},
journal = {Congenital Anomalies},
year = {2026},
volume = {66},
number = {1},
doi = {10.1002/cga.70062}
}
EUVIMED